Literature DB >> 6251960

Fanconi anemia. Oxymetholone hepatic tumors, and chromosome aberrations associated with leukemic transition.

D A Obeid, F G Hill, D Harnden, J R Mann, B S Wood.   

Abstract

Jaundice and hepatomegaly developed in a boy with Fanconi anemia after he had undergone treatment with oxymetholone for nine years. A liver scan showed patchy uptake consistent with the presence of space-occupying lesions. After oxymetholone treatment was stopped, the jaundice resolved, the liver size decreased, and the filling defects were no longer detectable on the liver scan. A year later, 5% of his white blood cells showed a consistent chromosomal abnormality. His leukocyte count increased and 85% of these cells showed the same chromosomal abnormality. The rapid replication of this abnormal clone suggests that it was leukemic. The significance of oxymetholone therapy and the occurrence of hepatic tumors and leukemia is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251960     DOI: 10.1002/1097-0142(19800915)46:6<1401::aid-cncr2820460619>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Toxicity and carcinogenicity of androstenedione in F344/N rats and B6C3F1 mice.

Authors:  Chad R Blystone; Susan A Elmore; Kristine L Witt; David E Malarkey; Paul M D Foster
Journal:  Food Chem Toxicol       Date:  2011-05-30       Impact factor: 6.023

2.  Hepatic tumours during androgen therapy in Fanconi anaemia.

Authors:  R L Touraine; Y Bertrand; P Foray; J Gilly; N Philippe
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.